Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Body Dysmorphic Disorders

ClinicalTrials.gov lists 56 trials for Body Dysmorphic Disorders or a narrower condition beneath it.

MeSH D057215 Mental Disorders F03
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 2 Phase 2 5 Phase 3 Phase 3 1 Phase 4 Phase 4 3 Not applicable Not applicable 35 Observational Observational 11 Phase 1 Phase 1 1 Phase 2 Phase 2 5 Phase 3 Phase 3 1 Phase 4 Phase 4 3 Not applicable Not applicable 35 Observational Observational 11

Trials per phase (log scale)

56 of the 56 trials are tagged with Body Dysmorphic Disorders itself; the rest are tagged with a narrower condition beneath it.

Get the Body Dysmorphic Disorders report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Body Dysmorphic Disorders trials start? (20)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 8

2004: 3 trials (Not applicable 1, Phase 4 2) 2005: 2 trials (Observational 1, Phase 3 1) 2007: 1 trials (Phase 2 1) 2008: 3 trials (Observational 1, Phase 4 1, Phase 1 1) 2009: 4 trials (Not applicable 4) 2010: 1 trials (Not applicable 1) 2011: 2 trials (Observational 1, Not applicable 1) 2013: 1 trials (Not applicable 1) 2014: 1 trials (Phase 2 1) 2015: 1 trials (Not applicable 1) 2016: 2 trials (Not applicable 1, Phase 2 1) 2017: 3 trials (Not applicable 3) 2019: 3 trials (Observational 1, Not applicable 2) 2020: 2 trials (Observational 1, Not applicable 1) 2021: 4 trials (Observational 1, Not applicable 2, Phase 2 1) 2022: 8 trials (Observational 2, Not applicable 5, Phase 2 1) 2023: 3 trials (Observational 1, Not applicable 2) 2024: 5 trials (Not applicable 5) 2025: 4 trials (Observational 1, Not applicable 3)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 4
2024 5
2023 3
2022 8
2021 4
2020 2
2019 3
2017 3
2016 2

No forecast is made for this condition: it averages 4.8 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 25 months from start to primary completion across 9 trials still running at the 2026-10-09 snapshot; registered median of 21 months across 39 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Body Dysmorphic Disorders trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 2 5
Phase 3 1
Phase 4 3
Not applicable 35
Observational 11

How many Body Dysmorphic Disorders trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 8
Active, not recruiting 5
Completed 35
Terminated 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for Body Dysmorphic Disorders? (2)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
D-Cycloserine 1
Milk Thistle 1

Interventions as named in the registry (10)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Prozac Pulvules 40 mg 2
IM Oxytocin 1
Levetiracetam XR 1
Positron Emission Tomography using [11C]diprenorphine 1
memantine ER 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Body Dysmorphic Disorders trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Suicidal ideation 2 1
Anaphylactic shock 1 1
Cardiac surgery 1 1
Increase in BDD and depressive Symptoms 1 1
Increased depression and suicidal ideation 1 1

Which publications cover Body Dysmorphic Disorders? (63)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages